Articles Mentioning Life Sciences Tools and Services Stocks

Results 11 - 20 of 379 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Life Sciences Tools and Services

Investing | March 28, 2014

4 Disruptive Stocks Biotechs Depend On

Contract research organizations Quintiles (Q), Icon PLC (ICLR), Covance (CVD), and Parexel (PRXL) are redefining how biopharma discovers and develops new therapies.

Investing | March 21, 2014

1 Great Dividend You Can Buy Right Now

Shareholders in this diagnostics company have witnessed their dividend grow by 340% over the past decade, and that could be just the tip of the iceberg.

Investing | March 06, 2014

3 Reasons to Buy 2014's Smartest Company

Gene sequencing stock Illumina has exploded onto the scene with huge gains for investors, but could the best be yet to come for this exciting company?

Investing | March 03, 2014

PacBio, the Post-Hype Sleeper of Genomics

PacBio, the post-hype sleeper of genomics.

Investing | February 10, 2014

Europe Isn't Weighing Down Mettler-Toledo Anymore

The market for lab equipment is improving in Europe and the U.S., boosting results for Mettler Toledo.

Investing | January 27, 2014

Is Thermo Fisher Scientific Inc. Destined for Greatness?

Diagnostics leader Thermo-Fisher (TMO) could soon make a huge splash in genomics, but it's got plenty of other irons in the fire as well.

Investing | January 23, 2014

When Will the Sub-$1,000 Human Genome Arrive?

The media swarmed over Illumina's announcement of a system capable of sequencing a human genome for $1,000 in the near future, but when will the company and Thermo Fisher Scientific break that barrier on a routine basis?

Investing | January 22, 2014

2014: The Year of Personalized Medicine

After a 2013 of massive improvements to cancer therapy, will 2014 be the year doctors can quickly determine which patients will benefit from which therapies?

Investing | January 22, 2014

The $1,000 Genome Marks the Start of a New Phase in Human Evolution

Unlocking the "human code" makes possible all manner of changes we might have never considered before. Are we ready for what that might mean?

Investing | January 22, 2014

Why You Need to Watch Teva, AMAG, AstraZeneca, and Nektar Therapeutics This Morning

Teva Pharmaceutical, AMAG Pharmaceuticals, AstraZeneca, and Nektar Therapeutics could loom large in health-care headlines this morning. Here’s why.

Results 11 - 20 of 379 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Life Sciences Tools and Services